A neuropharmacological model to explain buprenorphine induction challenges

MK Greenwald, AA Herring, J Perrone… - Annals of Emergency …, 2022 - Elsevier
Buprenorphine induction for treating opioid use disorder is being implemented in
emergency care. During this era of high-potency synthetic opioid use, novel and divergent …

Prescribing buprenorphine for opioid use disorders in the ED: a review of best practices, barriers, and future directions

SS Cao, SI Dunham, SA Simpson - Open Access Emergency …, 2020 - Taylor & Francis
ED-initiated addiction treatment holds promise for enhancing access to treatment for those
with opioid use disorder (OUD). We present a literature review summarizing the evidence for …

Opioid withdrawal symptoms, frequency, and pain characteristics as correlates of health risk among people who inject drugs

RN Bluthenthal, K Simpson, RC Ceasar, J Zhao… - Drug and alcohol …, 2020 - Elsevier
Objective Opioid withdrawal symptoms are widely understood to contribute to health risk but
have rarely been measured in community samples of opioid using people who inject drugs …

Management of opioid use disorder in the emergency department: a white paper prepared for the American Academy of Emergency Medicine

RJ Strayer, K Hawk, BD Hayes, AA Herring… - The Journal of …, 2020 - Elsevier
Over 2 million Americans misuse prescription or illicitly obtained opioids, and opioid
overdose deaths rose to a record 47,600 in 2017, representing a nearly 600% increase in …

A novel social work approach to emergency department buprenorphine induction and warm hand-off to community providers

T Kelly, JA Hoppe, M Zuckerman, A Khoshnoud… - The American journal of …, 2020 - Elsevier
Study objective Medications for opioid use disorder (MOUD) is considered gold standard
treatment for persons with an opioid use disorder and can be successfully initiated in …

Emergency department interventions for opioid use disorder: A synthesis of emerging models

CP Thomas, MT Stewart, C Tschampl… - Journal of Substance …, 2022 - Elsevier
Introduction Opioid overdose deaths are increasing, and improving access to evidence-
based treatment is necessary. Emergency department (ED) initiation of treatment for opioid …

[HTML][HTML] Predictors of enrollment in opioid agonist therapy after opioid overdose or diagnosis with opioid use disorder: a cohort study

A Macmadu, K Paull, R Youssef, S Batthala… - Drug and alcohol …, 2021 - Elsevier
Background Medicaid recipients have a high burden of opioid overdose and opioid use
disorder (OUD). Opioid agonist therapies are an effective treatment for OUD, but there is a …

“Narcan encounters:” overdose and naloxone rescue experiences among people who use opioids

LS Kahn, M Wozniak, BM Vest, C Moore - Substance abuse, 2022 - journals.sagepub.com
Background Communities across the United States are confronting the precipitous rise in
opioid overdose fatalities that has occurred over the past decade. Naloxone, an opioid …

The adverse impact of COVID-19 on individuals with OUD highlights the urgent need for reform to leverage emergency department–based treatment

G D'Onofrio, A Venkatesh, K Hawk - NEJM Catalyst Innovations in …, 2020 - catalyst.nejm.org
The Adverse Impact of Covid-19 on Individuals with OUD Highlights the Urgent Need for
Reform to Leverage Emergency Department–Based Treatment | NEJM Catalyst Skip to …

R-(−)-ketamine modifies behavioral effects of morphine predicting efficacy as a novel therapy for opioid use disorder1

JM Witkin, J Kranzler, K Kaniecki, P Popik… - Pharmacology …, 2020 - Elsevier
Substance abuse disorder continues to have devastating consequences for individuals and
society and current therapies are not sufficient to provide the magnitude of medical impact …